• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    LivaNova PLC - Ordinary Shares (NQ:LIVN)

    81.05 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Jun 25, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 158
    Open 81.05
    Bid (Size) 78.07 (100)
    Ask (Size) 84.90 (100)
    Prev. Close 81.05
    Today's Range 81.05 - 81.05
    52wk Range 41.02 - 82.66
    Shares Outstanding 49,023,767
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    LivaNova to Announce Second-Quarter 2026 Results
    From LivaNova PLC
    Via Business Wire
    News headline image
    LivaNova Demonstrates 84.5% Cumulative Response Rate with PolySync Programming in OSPREY Study for Obstructive Sleep Apnea
    From LivaNova PLC
    Via Business Wire

    Performance

    YTD
    +33.7%
    +33.7%
    1 Month
    +7.5%
    +7.5%
    3 Month
    +27.3%
    +27.3%
    6 Month
    +28.9%
    +28.9%
    1 Year
    +76.7%
    +76.7%

    More News

    Read More
    News headline image
    Jette Nygaard-Andersen Joins LivaNova Board as a New Director
    From LivaNova PLC
    Via Business Wire
    News headline image
    LivaNova Appoints Anne Liddy as Chief Legal Officer
    From LivaNova PLC
    Via Business Wire
    LivaNova PLC (NASDAQ:LIVN) Beats Q1 Estimates, Lifts Full-Year Guidance ↗
    Via Chartmill
    LivaNova (NASDAQ:LIVN) Beats Q4 Estimates, Provides Steady 2026 Outlook ↗
    Via Chartmill
    News headline image
    LivaNova Appoints Stefano Folli to Lead its Cardiopulmonary Business Unit
    From LivaNova PLC
    Via Business Wire
    News headline image
    LivaNova to Present at Goldman Sachs Global Healthcare Conference in June
    From LivaNova PLC
    Via Business Wire
    News headline image
    LivaNova (LIVN) Q1 2025 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    LivaNova (LIVN) Q2 2025 Earnings Transcript ↗
    Via The Motley Fool
    Topics Supply Chain
    News headline image
    LivaNova (LIVN) Q3 2025 Earnings Transcript ↗
    Via The Motley Fool
    Topics World Trade
    News headline image
    LivaNova (LIVN) Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    LivaNova Reports First-Quarter 2026 Results; Raises Full-Year 2026 Revenue and Adjusted Diluted EPS Guidance
    From LivaNova PLC
    Via Business Wire
    News headline image
    Annals of Internal Medicine Publishes 12-Month Results from LivaNova’s OSPREY Clinical Study for Obstructive Sleep Apnea
    From LivaNova PLC
    Via Business Wire
    News headline image
    LivaNova to Announce First-Quarter 2026 Results
    From LivaNova PLC
    Via Business Wire
    News headline image
    LivaNova Receives U.S. Food and Drug Administration Premarket Approval for aura6000 System to treat Moderate to Severe Obstructive Sleep Apnea
    From LivaNova PLC
    Via Business Wire
    News headline image
    LivaNova (LIVN) Q4 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings World Trade
    News headline image
    LivaNova Reports Fourth-Quarter and Full-Year 2025 Results; Issues 2026 Guidance
    From LivaNova PLC
    Via Business Wire
    News headline image
    LivaNova to Announce Fourth-Quarter and Full-Year 2025 Results
    From LivaNova PLC
    Via Business Wire
    News headline image
    LivaNova to Present at J.P. Morgan Healthcare Conference in January
    From LivaNova PLC
    Via Business Wire
    News headline image
    LivaNova to Highlight Real-World Evidence from CORE-VNS Study and New Health Economics Analyses at American Epilepsy Society 2025 Annual Meeting
    From LivaNova PLC
    Via Business Wire
    News headline image
    LivaNova Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea
    From LivaNova PLC
    Via Business Wire
    News headline image
    LivaNova to Present at Piper Sandler Healthcare Conference in December
    From LivaNova PLC
    Via Business Wire
    News headline image
    LivaNova’s VNS Therapy for Drug-Resistant Epilepsy Procedures Receives Increased Provider Reimbursement from U.S. Centers for Medicare & Medicaid Services
    From LivaNova PLC
    Via Business Wire
    News headline image
    LivaNova Delivers Strategic Roadmap and Long-Range Financial Plan at Investor Day
    From LivaNova PLC
    Via Business Wire

    Frequently Asked Questions

    Is LivaNova PLC - Ordinary Shares publicly traded?
    Yes, LivaNova PLC - Ordinary Shares is publicly traded.
    What exchange does LivaNova PLC - Ordinary Shares trade on?
    LivaNova PLC - Ordinary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for LivaNova PLC - Ordinary Shares?
    The ticker symbol for LivaNova PLC - Ordinary Shares is LIVN on the Nasdaq Stock Market
    What is the current price of LivaNova PLC - Ordinary Shares?
    The current price of LivaNova PLC - Ordinary Shares is 81.05
    When was LivaNova PLC - Ordinary Shares last traded?
    The last trade of LivaNova PLC - Ordinary Shares was at 06/25/26 04:00 PM ET
    What is the market capitalization of LivaNova PLC - Ordinary Shares?
    The market capitalization of LivaNova PLC - Ordinary Shares is 3.97B
    How many shares of LivaNova PLC - Ordinary Shares are outstanding?
    LivaNova PLC - Ordinary Shares has 4B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.